Trial Profile
Safety, pharmacokinetics, pharmacodynamics and efficacy of Voxtalisib in patients with relapsed/refractory lymphoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Voxtalisib (Primary)
- Indications Lymphoma; Solid tumours
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 16 May 2016 New trial record